“…This approach enables large excesses of reagents and activating agents to be used to drive peptide bond-forming reactions to completion and avoids handling problems associated with the poor solubility and aggregation of medium-length peptides. 6,207 A significant amount of research has been carried out in improving the efficiency of solid-phase protocols, including studies on the use of different protecting groups (e.g., N-FMoc vs. N-Boc, O-Bn vs. O-t Bu), 189,194,208 optimization of the performance of different polymer supports (e.g., Merrifield vs. PEGA), 209-216 the use of different coupling reagents (e.g., phosphonium vs. uronium salts), 154 variation in the point of attachment of the peptide (e.g., N-terminus vs. side chain vs. backbone amide), 217 and optimization of the linker/cleavage conditions employed to attach/release peptides to/from solid support. 218 Manual solid-phase peptide synthesis may be performed using inexpensive protocols that employ syringes fitted with filters, 6 or using variations of the polypropylene 'Teabag' technology developed by Houghten and coworkers.…”